advanced nonhematologic malignancies
Showing 1 - 5 of 5
Advanced Nonhematologic Malignancies Trial in Worldwide (MLN2480, MLN0128, Alisertib)
Completed
- Advanced Nonhematologic Malignancies
- MLN2480
- +5 more
-
Boston, Massachusetts
- +13 more
Feb 11, 2020
Advanced Nonhematologic Malignancies Trial in Spain, United Kingdom, United States (TAK-228, TAK-117)
Completed
- Advanced Nonhematologic Malignancies
-
Boston, Massachusetts
- +4 more
Oct 7, 2019
Advanced Nonhematologic Malignancies Trial in San Antonio (TAK-733 and alisertib)
Withdrawn
- Advanced Nonhematologic Malignancies
- TAK-733 and alisertib
-
San Antonio, TexasSouth Texas Accelerated Research Therapeutics (START)
Oct 31, 2013
Advanced Nonhematologic Malignancies, Carcinoma, Basal Cell Trial in Scottsdale, Santa Monica (TAK-441)
Completed
- Advanced Nonhematologic Malignancies
- Carcinoma, Basal Cell
-
Scottsdale, Arizona
- +1 more
Jul 1, 2013